Monday, July 20, 2020 12:26:23 PM
Vystar Corporation
@VystarCompany
·
May 9, 2019
As promised first RXAIR distributor deal closed today with 100+ units 200%+ markup, purchased & paid for. Vystar has ample stock remaining for retail & distributor sales. Additional container orders will be placed shortly. Tariffs remain unchanged for medical devices.
A year later and how many units sold??
Vystar Corporation
@VystarCompany
·
May 28, 2019
Vystar Acquires Fluid Energy Conversion Technology Assets, Expands Reach Into New Vertical Markets $VYST
No News on this after the tweet
Vystar Corporation
@VystarCompany
·
Aug 26, 2019
Just got in the new samples of Vytex exam gloves. They look & feel great. Gives all the benefits of latex, stronger, thinner better tactile feel, but Eliminates latex allergies. $VYST
No news on glove sales, after this tweet
Vystar Corporation
@VystarCompany
·
Oct 16, 2019
Vystar Plans Dividend Spin-Off of RxAir totaling approximately $6 million, as a separate, independent, publicly-traded company. $VYST
Noted "planned" spin off...nothing has come of this since tweet
Vystar Corporation
@VystarCompany
·
Dec 2, 2019
Shareholders have asked about a press schedule, now that the filings are out of the way, shortly, will have a corporate update out with the companies game plan for the future & you can expect a fairly robust press schedule. We will continue to use Twitter for updates. $VYST
Robust Press Schedule?! No PRs or tweets from Company from dec 24, 2019 to March 24, 2020
This does not even broach the topics of:
**Buyback of stock...$30 were actually bought back
**The Investment Bankers talks from June 2019...nothing came of those talks!?
**Investment Bankers talks from December 2019...what came of that?!
HOW DO YOU RESPOND TO ALL THIS?
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM